NIH #R44CA224848
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
- Amount
- $800K–$900K
- Period
- 2019-09-18 → 2021-08-31
- PIs
- 1
Awarded at BIOFLUIDICA, INC
Microbial Natural Products and Biosynthesis · Pharmacology
Compare more Pharmacology professors.
6 total · 0 active
NIH #R44CA224848
Awarded at BIOFLUIDICA, INC
NIH #R43HD098942
Awarded at BIOFLUIDICA, INC
NIH #R43CA232848
Awarded at BIOFLUIDICA, INC
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data may not be current
ORCID: 0000-0002-1042-5665